• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clinical Features of Fatal Pandemic Influenza A/H1N1 Infection Complicated by Invasive Pulmonary Fungal Infection

tetano

Editor, Senior Moderator
Mycopathologia. 2019 Dec 27. doi: 10.1007/s11046-019-00421-z. [Epub ahead of print] [h=1]Clinical Features of Fatal Pandemic Influenza A/H1N1 Infection Complicated by Invasive Pulmonary Fungal Infection.[/h]
Yu Z[SUP]1[/SUP], Gu Q[SUP]1[/SUP], Zhang B[SUP]1[/SUP], Chen X[SUP]1[/SUP], Tang J[SUP]1[/SUP], Hou Y[SUP]1[/SUP], Yu W[SUP]2[/SUP].
[h=3]Author information[/h] 1 Nanjing University Medical School Affiliated Nanjing Drum Tower Hospital, Nanjing, China. 2 Nanjing University Medical School Affiliated Nanjing Drum Tower Hospital, Nanjing, China. yudrnj@163.com.

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Severe pneumonia caused by influenza virus infection can be secondary to invasive pulmonary fungal (IPF) infection.
[h=4]OBJECTIVES:[/h] This study aimed to summarize the incidence of IPF infection secondary to influenza virus infection and further explore its etiologic mechanism and high-risk factors.
[h=4]METHODS:[/h] All adult patients with confirmed influenza A (H1N1) virus infection admitted to the intensive care units (ICUs) of Nanjing Drum Hospital from November 2017 to March 2018 were retrospectively selected. The differences in baseline factors, risk factors, immune function and outcome parameters were studied between patients with and without IPF.
[h=4]RESULTS:[/h] Of the 19 critically ill patients with H1N1 infection, 11 (57.9%) developed IPF infection after 7 days of ICU admission. Two patients had proven and nine probable IPF infection. A difference in human leukocyte antigen-DR isotype (△HLA-DR; day 7-day 1) was found between the two groups. △HLA-DR (day 7-day 1) was higher in patients with no IPF infection than in those with IPF infection [(14.52 ? 14.21)% vs ( - 11.74 ? 20.22)%, P = 0.019]. The decline in HLA-DR indicated impaired immune function secondary to fungal infection in patients with H1N1 infection.
[h=4]CONCLUSIONS:[/h] IPF infection was diagnosed in 57.9% of critically ill patients with H1N1 virus infection after a median of 7 days following ICU admission. A continuous decline in immune function could lead to the development of IPF infections. Dynamic monitoring of immune function may help in the early detection of IPF infection.


[h=4]KEYWORDS:[/h] H1N1; Human leukocyte antigen-DR isotype (HLA-DR); Invasive pulmonary fungal infection; Severe pneumonia

PMID: 31883036 DOI: 10.1007/s11046-019-00421-z
 
Back
Top